Voice Under Tension: The Hidden Role of the Restrictive Sublingual Fascia

Objectives
Current clinical guidelines (AAP 2024) do not address voice or resonance outcomes in ankyloglossia — reflecting a genuine evidence gap, not a negative finding. This presentation aims to (1) map the mechanistic pathway from restrictive sublingual fascia to Muscle Tension Dysphonia (MTD); (2) synthesise the best available evidence on voice outcomes following Sublingual Fascia Release (SFR) combined with Orofacial Myofunctional Therapy (OMT); and (3) provide clinicians across disciplines with evidence-based red flags and a shared diagnostic framework.

Methodology
Narrative evidence synthesis of peer-reviewed literature published 2021–2025, including prospective cohort studies, systematic reviews, meta-analyses, and a CBCT-documented case study. Evidence was critically appraised using GRADE criteria. Anatomical reasoning draws on established myofascial chain models (Thomas Myers' Deep Front Line) and quantitative acoustic analysis data from the Voice Foundation Annual Symposium 2025.

Results
A clear anatomical cascade emerges: restrictive sublingual fascia → suprahyoid hypertonicity → hyoid malposition → infrahyoid compensation → laryngeal loading → MTD. The hyoid — the only freely suspended bone in the body — functions as the central pivot of the vocal system; any upstream restriction transmits directly to the larynx and pharyngeal wall.

Key evidence:
• Baxter et al. (2023, Int J Orofacial Myol, n = 12): 91.6% of professional voice users reported improved voice quality, pitch range, endurance, and breath support following SFR + OMT.
• Zaghi et al. (2025, Int J Orofacial Myol, n = 445): fascia-sparing CO₂ laser protocol with structured OMT yielded 86% patient satisfaction; post-operative pain dropped from 15.8% to 3.7%; revision rate from 6.6% to 2.1%.
• Voice Foundation 2025 (classical soprano, CBCT): objective acoustic gains post-frenectomy — jitter −29.4%, shimmer −20.5%, vocal range +1 octave, dynamic variance +116.5%, maximum phonation time +7.8 s; CBCT confirmed 5.8 mm hyoid descent and 50.6% reduction in pharyngeal collapsibility.
• Barsties v. Latoszek (2024, Laryngoscope, meta-analysis): circumlaryngeal manual therapy at the hyoid/larynx significantly reduces MTD, sometimes after a single session, with measurable improvements in shimmer and HNR.

Articulation research (Wang 2022; Kummer 2023) shows weak-to-contradictory evidence for a direct causal link between tongue-tie and speech errors — because the brain compensates at any cost. The pathology is not the speech error; it is the chronic muscular overload sustaining it. No RCTs with voice parameters as primary endpoints currently exist.

Implications
Restrictive sublingual fascia is an underrecognised upstream driver of vocal pathology. Absent lisping does not equal absent pathology. SFR combined with structured OMT constitutes a clinically viable adjunctive intervention for MTD in patients with confirmed ankyloglossia, within a coordinated interdisciplinary framework involving SLP/voice therapy, ENT/phoniatrics, dentistry, and physiotherapy. Voice and resonance outcomes should be established as primary endpoints in future RCTs, alongside standardised ankyloglossia classification to enable cross-study comparison.

Keywords: ankyloglossia; sublingual fascia release; muscle tension dysphonia; hyoid; voice quality